Ethyl glucuronide (EtG) antibody and antigen (hapten, BSA/OVA conjugated)

Diagnostic anti-Ethyl glucuronide (EtG) antibodies (anti-Ethyl glucuronide, anti-EtG) and diagnostic hapten-carrier conjugates BSA-Ethyl glucuronide (EtG), OVA-Ethyl glucuronide (EtG), KLH-Ethyl glucuronide (EtG) antigens for Metabolic diseases EtG detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-SMT-231-Ag01 BSA-Ethyl glucuronide (EtG) 756
GMP-SMT-231-Ag02 OVA-Ethyl glucuronide (EtG) 756
GMP-SMT-231-Ab01 Anti-human Ethyl glucuronide (EtG) mouse monoclonal antibody (mAb) 1953
GMP-SMT-231-Ab02 Anti-human Ethyl glucuronide (EtG) human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-SMT-231-Ag01
Product Name BSA-Ethyl glucuronide (EtG)
Target/Biomarker Ethyl glucuronide (EtG)
Expression platform Synthetic
Isotypes NA
Bioactivity validation Ethyl glucuronide (EtG) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in EtG level test of Metabolic diseases () and related syndrome evaluation.
Tag NA
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Ethyl glucuronide (EtG) / OVA-Ethyl glucuronide (EtG) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-SMT-231-Ag02
Product Name OVA-Ethyl glucuronide (EtG)
Target/Biomarker Ethyl glucuronide (EtG)
Expression platform Synthetic
Isotypes NA
Bioactivity validation Ethyl glucuronide (EtG) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in EtG level test of Metabolic diseases () and related syndrome evaluation.
Tag NA
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Ethyl glucuronide (EtG) / OVA-Ethyl glucuronide (EtG) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-SMT-231-Ab01
Product Name Anti-human Ethyl glucuronide (EtG) mouse monoclonal antibody (mAb)
Target/Biomarker Ethyl glucuronide (EtG)
Expression platform Hybridoma
Isotypes Mouse IgG
Bioactivity validation Ethyl glucuronide (EtG) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in EtG level test of Metabolic diseases () and related syndrome evaluation.
Tag mFc
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Ethyl glucuronide (EtG) / OVA-Ethyl glucuronide (EtG) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-SMT-231-Ab02
Product Name Anti-human Ethyl glucuronide (EtG) human monoclonal antibody (mAb)
Target/Biomarker Ethyl glucuronide (EtG)
Expression platform Hybridoma
Isotypes Mouse IgG
Bioactivity validation Ethyl glucuronide (EtG) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in EtG level test of Metabolic diseases () and related syndrome evaluation.
Tag mFc
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Ethyl glucuronide (EtG) / OVA-Ethyl glucuronide (EtG) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Ethyl Glucuronide (EtG) and its Role in In Vitro Diagnosis (IVD): Ethyl glucuronide, known as EtG, is a metabolite of ethanol (alcohol) that holds immense significance in the realm of in vitro diagnosis (IVD). It serves as a robust biomarker for the accurate and sensitive detection of recent alcohol consumption, offering invaluable insights across various domains. Our company specializes in providing a comprehensive range of anti-Ethyl glucuronide antibodies and small molecule competitive antigens, including Carrier-coupled antigens, immunogens, hapten-carrier conjugates, Bovine Serum Albumin (BSA)-conjugated, and Ovalbumin (OVA)-conjugated variants. These meticulously engineered reagents are tailored to enable precise and reliable quantification of Ethyl glucuronide in diverse sample matrices. The Clinical Relevance of Ethyl Glucuronide Measurement: a. Alcohol Monitoring: Ethyl glucuronide stands as a dependable marker for recent alcohol consumption. Its presence in bodily fluids, such as urine or blood, is indicative of recent alcohol intake. This feature makes it an indispensable tool for monitoring individuals in substance abuse treatment programs, aiding healthcare providers in assessing adherence to sobriety and supporting individuals on their path to recovery. b. Forensic and Legal Investigations: In forensic science and legal proceedings, the accurate determination of recent alcohol use is often crucial. Ethyl glucuronide testing plays a pivotal role in these contexts by providing compelling evidence of recent alcohol consumption. It aids in the elucidation of cases involving alcohol-related incidents, accidents, or disputes, contributing to the establishment of legal outcomes. c. Occupational Safety: Certain occupational settings necessitate stringent alcohol-use monitoring to mitigate safety risks. Ethyl glucuronide testing is employed to ensure compliance with workplace regulations and standards, particularly in industries where alcohol use could endanger employee well-being or public safety. This includes professions such as aviation, transportation, and heavy machinery operation. d. Clinical Applications: In the realm of clinical diagnostics, Ethyl glucuronide testing offers valuable insights, especially when managing patients with alcohol-related health conditions. Patients with liver disease, for example, may require strict abstinence from alcohol to ensure treatment effectiveness. Ethyl glucuronide measurement aids healthcare providers in assessing abstinence compliance, thereby enhancing patient care and optimizing treatment outcomes. e. Personalized Medicine: Ethyl glucuronide testing can be instrumental in the emerging field of personalized medicine. Tailoring treatment plans based on an individual's ability to abstain from alcohol can improve the efficacy of therapeutic interventions, minimizing the risk of adverse events and optimizing patient outcomes. Our Commitment to Accurate Ethyl Glucuronide Detection: Genemedi is dedicated to advancing the field of Ethyl glucuronide detection by offering a comprehensive suite of specialized tools and resources. Our anti-Ethyl glucuronide antibodies and competitive antigens are meticulously designed and rigorously tested to ensure the highest levels of specificity and sensitivity in Ethyl glucuronide quantification. By harnessing these cutting-edge bioreagents, researchers, clinicians, and forensic experts can confidently conduct meticulous analyses, enabling precise and reliable detection of Ethyl glucuronide across a wide range of sample types. In conclusion, the precise measurement of Ethyl glucuronide extends its significance into various clinical, forensic, safety, and regulatory domains. It empowers professionals in substance abuse treatment, forensic investigations, occupational safety, and clinical care to make informed decisions, enhance safety standards, and ensure compliance with sobriety requirements. Genemedi's specialized anti-Ethyl glucuronide antibodies and competitive antigens are pivotal in facilitating this precision, ultimately contributing to improved healthcare, safety, and the broader goals of public health and law enforcement.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment